Why the study?
OAC is relatively contraindicated after ICH if the cause cannot be eliminated, leaving AF patients at high risk of thromboembolism, making endovascular LAAC a potential alternative.
Does endovascular left atrial appendage closure reduce the rate of stroke or TIA compared to predicted rates in patients with nonvalvular atrial fibrillation and prior intracranial hemorrhage?
Population
138 consecutive ICH patients with nonvalvular AF and high stroke risk
Comparison
Observed stroke/TIA rates post-LAAC vs CHA2DS2-VASc-predicted event rates
Design
Retrospective single-centre analysis
Follow-up
Mean 14.7 ± 13.7 months
Key result
Left atrial appendage closure in patients with nonvalvular AF and prior ICH resulted in an annualized stroke/TIA rate of 1.8%, which was lower than the predicted rate of 7.0%.
Authors
Loading...
LAAC may support stroke prevention in AF with prior ICH; leaves open confirmation in randomized trials before practice change.
Cohort (n=138)
No
Does endovascular left atrial appendage closure reduce the rate of stroke or TIA compared to predicted rates in patients with nonvalvular atrial fibrillation and prior intracranial hemorrhage?
Absolute Event Rate: 1.8% vs 7%
Endovascular left atrial appendage closure is associated with a lower-than-predicted rate of stroke and TIA in patients with nonvalvular atrial fibrillation and prior intracranial hemorrhage, offering a feasible alternative to oral anticoagulation.
Gilhofer et al. (2023) conducted a cohort in Nonvalvular atrial fibrillation and prior intracranial hemorrhage (n=138). Endovascular left atrial appendage closure (LAAC) vs. Predicted event rate based on CHA2DS2-VASc scores was evaluated on Annualized stroke/TIA rate. Left atrial appendage closure in patients with nonvalvular AF and prior ICH resulted in an annualized stroke/TIA rate of 1.8%, which was lower than the predicted rate of 7.0%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: